Search research articles
Contact Us
Filters
Showing results (31-40 of 108) with videos related to
Page
of 11
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Sebastian Roemer-Cassiano, Shaoshi Zhang, Lisa Evangelista, et al.
Brain, Behavior, and Immunity
|
April 7, 2025
Higher blood-brain barrier leakage in schizophrenia-spectrum disorders: A comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls
Joanna Moussiopoulou, Vladislav Yakimov, Lukas Roell, et al.
Brain Sciences
|
February 25, 2022
Impact of Partial Volume Correction on [<sup>18</sup>F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome
Sebastian Schuster, Leonie Beyer, Carla Palleis, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
May 2, 2025
Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer's disease and corticobasal syndrome
Carolin Kurz, Laura Carli, Selim Üstün Gürsel, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 25, 2024
Aβ status assessment in a hypothetical scenario prior to treatment with disease-modifying therapies: Evidence from 10-year real-world experience at university memory clinics
Matthias Brendel, Tandis Parvizi, Johannes Gnörich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 5, 2021
Cortical [<sup>18</sup> F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes
Carla Palleis, Matthias Brendel, Anika Finze, et al.
Neurology
|
January 2, 2024
Association of Neurofilament Light Chain, [<sup>18</sup>F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS
Carla Palleis, Nicolai Franzmeier, Endy Weidinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 20, 2025
Comparing and combining TSPO-PET tracers in tauopathies
Harry Crook, Nicolai Franzmeier, Nesrine Rahmouni, et al.
Alzheimer'S Research & Therapy
|
March 18, 2025
Perivascular space and white matter hyperintensities in Alzheimer's disease: associations with disease progression and cognitive function
Philine Marie Schirge, Robert Perneczky, Toshiaki Taoka, et al.
Life (Basel, Switzerland)
|
June 2, 2021
Impact of TSPO Receptor Polymorphism on [<sup>18</sup>F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders
Franziska J Vettermann, Stefanie Harris, Julia Schmitt, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 108) with videos related to
Sort By:
Page
of 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Sebastian Roemer-Cassiano, Shaoshi Zhang, Lisa Evangelista, et al.
Brain, Behavior, and Immunity
|
April 7, 2025
Higher blood-brain barrier leakage in schizophrenia-spectrum disorders: A comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls
Joanna Moussiopoulou, Vladislav Yakimov, Lukas Roell, et al.
Brain Sciences
|
February 25, 2022
Impact of Partial Volume Correction on [<sup>18</sup>F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome
Sebastian Schuster, Leonie Beyer, Carla Palleis, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
May 2, 2025
Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer's disease and corticobasal syndrome
Carolin Kurz, Laura Carli, Selim Üstün Gürsel, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 25, 2024
Aβ status assessment in a hypothetical scenario prior to treatment with disease-modifying therapies: Evidence from 10-year real-world experience at university memory clinics
Matthias Brendel, Tandis Parvizi, Johannes Gnörich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 5, 2021
Cortical [<sup>18</sup> F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes
Carla Palleis, Matthias Brendel, Anika Finze, et al.
Neurology
|
January 2, 2024
Association of Neurofilament Light Chain, [<sup>18</sup>F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS
Carla Palleis, Nicolai Franzmeier, Endy Weidinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 20, 2025
Comparing and combining TSPO-PET tracers in tauopathies
Harry Crook, Nicolai Franzmeier, Nesrine Rahmouni, et al.
Alzheimer'S Research & Therapy
|
March 18, 2025
Perivascular space and white matter hyperintensities in Alzheimer's disease: associations with disease progression and cognitive function
Philine Marie Schirge, Robert Perneczky, Toshiaki Taoka, et al.
Life (Basel, Switzerland)
|
June 2, 2021
Impact of TSPO Receptor Polymorphism on [<sup>18</sup>F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders
Franziska J Vettermann, Stefanie Harris, Julia Schmitt, et al.
Page
of 11